Ameren Corporation reported second-quarter 2026 diluted earnings per share of USD 1.13, beating the consensus estimate of USD 1.08 and exceeding last year's performance. Despite this earnings beat, revenue declined by 5.80 percent to USD 2.09 billion compared to the same quarter in the prior year. The company reaffirmed its full-year 2026 diluted earnings guidance range of USD 5.25 to USD 5.45 per share, maintaining a defined outlook for investors. Following the earnings release, major investment banks adjusted their price targets downward, signaling a more cautious valuation debate surrounding the regulated utility. Mizuho Securities cut its target from USD 124 to USD 113, while Morgan Stanley and Royal Bank of Canada also lowered their respective targets in late September. Although these analyst downgrades suggest concerns regarding interest costs, weather variability, and regulatory execution, the overall analyst sentiment remains positive with a majority of Buy ratings. Ameren stock is currently trading below its yearly high, with shares listed on the NYSE at approximately USD 99.38 as of late September 2026. The company holds a market capitalization of USD 27.5 billion and trades within a 52-week range of USD 96.57 to USD 118.32. While the stock price has dipped slightly in early October, the divergence between strong earnings performance and lower analyst targets highlights the specific risks impacting the utility's valuation multiple.